Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Craig Jordan

Showing results (101-110 of 218) with videos related to

Pageof 22
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|June 13, 2009
Potential of selective estrogen receptor modulators as treatments and preventives of breast cancerJing Peng, Surojeet Sengupta, V Craig Jordan
Breast Cancer Research : BCR|June 13, 2009
Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?Joan S Lewis-Wambi, V Craig Jordan
International Journal of Oncology|March 8, 2014
Mechanisms underlying differential response to estrogen-induced apoptosis in long-term estrogen-deprived breast cancer cellsElizabeth E Sweeney, Ping Fan, V Craig Jordan
Breast Cancer (Tokyo, Japan)|August 28, 2002
In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancerHiroyuki Takei, Eun-Sook Lee, V Craig Jordan
The Journal of Biological Chemistry|December 24, 2002
Modulation of estrogen receptor alpha function and stability by tamoxifen and a critical amino acid (Asp-538) in helix 12Sandra Timm Pearce, Hong Liu, V Craig Jordan
BMC Medicine|June 6, 2015
Obesity and male breast cancer: provocative parallels?Matthew P Humphries, V Craig Jordan, Valerie Speirs
JAMA Oncology|October 9, 2015
Progesterone and Synthetic Progestin ControversiesV Craig Jordan, Philipp Y Maximov, Ping Fan
Breast Cancer Research and Treatment|December 7, 2013
Cyclin dependent kinase-9 mediated transcriptional de-regulation of cMYC as a critical determinant of endocrine-therapy resistance in breast cancersSurojeet Sengupta, Michael C Biarnes, V Craig Jordan
Cancer Research|October 12, 2014
Molecular modulation of estrogen-induced apoptosis by synthetic progestins in hormone replacement therapy: an insight into the women's health initiative studyElizabeth E Sweeney, Ping Fan, V Craig Jordan
Journal of the National Cancer Institute|April 4, 2015
Estrogen receptor mutations found in breast cancer metastases integrated with the molecular pharmacology of selective ER modulatorsV Craig Jordan, Ramona Curpan, Philipp Y Maximov
Pageof 22

Showing results (101-110 of 218) with videos related to

Sort By:
Pageof 22
Anti-Cancer Agents in Medicinal Chemistry|June 13, 2009
Potential of selective estrogen receptor modulators as treatments and preventives of breast cancerJing Peng, Surojeet Sengupta, V Craig Jordan
Breast Cancer Research : BCR|June 13, 2009
Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?Joan S Lewis-Wambi, V Craig Jordan
International Journal of Oncology|March 8, 2014
Mechanisms underlying differential response to estrogen-induced apoptosis in long-term estrogen-deprived breast cancer cellsElizabeth E Sweeney, Ping Fan, V Craig Jordan
Breast Cancer (Tokyo, Japan)|August 28, 2002
In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancerHiroyuki Takei, Eun-Sook Lee, V Craig Jordan
The Journal of Biological Chemistry|December 24, 2002
Modulation of estrogen receptor alpha function and stability by tamoxifen and a critical amino acid (Asp-538) in helix 12Sandra Timm Pearce, Hong Liu, V Craig Jordan
BMC Medicine|June 6, 2015
Obesity and male breast cancer: provocative parallels?Matthew P Humphries, V Craig Jordan, Valerie Speirs
JAMA Oncology|October 9, 2015
Progesterone and Synthetic Progestin ControversiesV Craig Jordan, Philipp Y Maximov, Ping Fan
Breast Cancer Research and Treatment|December 7, 2013
Cyclin dependent kinase-9 mediated transcriptional de-regulation of cMYC as a critical determinant of endocrine-therapy resistance in breast cancersSurojeet Sengupta, Michael C Biarnes, V Craig Jordan
Cancer Research|October 12, 2014
Molecular modulation of estrogen-induced apoptosis by synthetic progestins in hormone replacement therapy: an insight into the women's health initiative studyElizabeth E Sweeney, Ping Fan, V Craig Jordan
Journal of the National Cancer Institute|April 4, 2015
Estrogen receptor mutations found in breast cancer metastases integrated with the molecular pharmacology of selective ER modulatorsV Craig Jordan, Ramona Curpan, Philipp Y Maximov
Pageof 22